0.9,bn

: Reported a "Group 1" financial metric of PLN 0.9bn in their Q4 2025 results, representing a 52.3% year-over-year increase. Government & Institutional Scaling

: Germany contributes €0.9bn to the total €3bn European market for in-vitro diagnostics, driven largely by diabetes testing. 0.9,bn

: In February 2026, open-ended funds saw outflows of $0.9bn , diverging from ETFs which saw significant inflows. Market Scale & Revenue : : Reported a "Group 1" financial metric of PLN 0

: Reported net outflows of £0.9bn for the first half of 2025, which was an improvement from the £2.0bn seen in 2024. open-ended funds saw outflows of $0.9bn